Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

H2O Innovation Ord Shs HEOFF

H2O Innovation Inc. is a Canada-based water solutions company, which is focused on providing technologies and services to its customers. The Company designs and provides custom-built, and integrated water treatment solutions based on membrane filtration technology for municipal, energy and natural resources end-users. The Company’s segments include Water Technologies & Services (WTS), Specialty Products (SP), and Operation & Maintenance (O&M). WTS segment designs and builds custom water, wastewater, and water reuse systems. It is engaged in applying membrane technologies and engineering expertise to deliver equipment and services to municipal and industrial water, wastewater, and water reuse customers. SP segment manufacture and supply a complete line of specialty chemicals, consumables, and engineered products for the global water treatment industry. O&M provides contract operations and associated services for water and wastewater treatment systems.


OTCQX:HEOFF - Post by User

Comment by Possibleidiot01on Feb 02, 2021 1:54pm
143 Views
Post# 32448335

RE:RE:RE:H2O Innovation acquires the rest of GMP

RE:RE:RE:H2O Innovation acquires the rest of GMP
Genesys’ consolidated financial results As at and for the year ended December 31, 2018 3 As at and for the six-month period ended June 30, 20194
Revenues £6.01 M ($10.40 M) £3.23 M ($5.57 M)
Adjusted EBITDA5 £1.94 M ($3.35 M) £0.94 M ($1.61 M)

The orginal purchase of the 24%  of GMP  for Genesys and some associated companies  was done for £16.95 M ($28.39 M)
or 9.76 x EBITDA for 2018.
The purchase of the remaining 76% wasdone at 6 x EBITA..
Done cheaply in other words . Done with working capital - no dilution involved.


<< Previous
Bullboard Posts
Next >>